Read + Share
Bernstein CN, Tenakoon A, Singh H, Targownik LE, et al. Continued 5ASA use after initiation of anti-TNF or immunomodulator confers no
benefit in IBD: a population-based study. Aliment Pharmacol Ther 2021;54:814-832.
PMID: 34247410
|
 |
|
Bernstein CN, Tenakoon A, Singh H, Targownik LE, et al. Continued 5ASA use after initiation of anti-TNF or immunomodulator confers no
benefit in IBD: a population-based study. Aliment Pharmacol Ther 2021;54:814-832.
PMID: 34247410
|
|
|
|